TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 151 filers reported holding TRANSLATE BIO INC in Q4 2020. The put-call ratio across all filers is 7.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $293,000 | -43.5% | 10,644 | -66.2% | 0.00% | -66.7% |
Q1 2021 | $519,000 | +140.3% | 31,472 | +168.0% | 0.00% | +50.0% |
Q4 2020 | $216,000 | -82.5% | 11,744 | -87.0% | 0.00% | -88.2% |
Q3 2020 | $1,232,000 | +215.9% | 90,553 | +316.4% | 0.02% | +183.3% |
Q2 2020 | $390,000 | +102.1% | 21,747 | -8.3% | 0.01% | +500.0% |
Q4 2019 | $193,000 | +50.8% | 23,711 | +83.6% | 0.00% | 0.0% |
Q3 2019 | $128,000 | – | 12,914 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Advisors, Inc. | 2,656,517 | $48,960,000 | 10.98% |
Copernicus Capital Management, LLC | 12,091 | $223,000 | 3.48% |
FRAZIER MANAGEMENT LLC | 2,182,789 | $40,229,000 | 3.10% |
Baupost Group | 18,044,239 | $326,236,000 | 3.01% |
DAFNA Capital Management LLC | 225,393 | $4,154,000 | 1.24% |
RTW INVESTMENTS, LP | 2,978,427 | $54,892,000 | 0.92% |
MARATHON CAPITAL MANAGEMENT | 143,275 | $2,640,000 | 0.78% |
Bain Capital Public Equity Management II, LLC | 627,387 | $11,563,000 | 0.59% |
Artal Group S.A. | 1,200,000 | $22,116,000 | 0.48% |
Birchview Capital, LP | 30,000 | $553,000 | 0.32% |